The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243 · cited 1×
“The −174 G/C variant has been shown to influence the transcriptional regulation of IL6, and human −174 G-allele carriers exhibit higher plasma IL-6 levels compared with homozygous C-allele carriers [14], an effect which is modulated by age and gender [15, 16].”
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 2×
“IL-6 is an important regulator of the acute phase response that is associated with insulin-resistant states including type 2 diabetes [7–10].”
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“[37] reported that IL6-deficient mice (IL6 mice) develop maturity-onset obesity with an expansion predominantly of subcutaneous fat tissue.”
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883
Interleukin-6 stimulates lipolysis and fat oxidation in humans
van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021687 · Cited by 767 · cited 1×
“Thus, it has been suggested that elevation of circulating IL-6 levels contributes to insulin resistance, type 2 diabetes [8, 10–12, 32–34], whereas other studies are consistent with an enhancing effect of IL-6 on glucose and lipid metabolism [3, 35, 36].”
Fernandez-Real, J.-M., Vayreda, M., Richart, C., Gutierrez, C., Broch, M., Vendrell, J., & Ricart, W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7305 · Cited by 567 · cited 1×
“Thus, it has been suggested that elevation of circulating IL-6 levels contributes to insulin resistance, type 2 diabetes [8, 10–12, 32–34], whereas other studies are consistent with an enhancing effect of IL-6 on glucose and lipid metabolism [3, 35, 36].”
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566
Cited by
Kristiansen, O. P., & Mandrup-Poulsen, T. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s114 · Cited by 524
Self-citationAzadbakht, L., & Esmaillzadeh, A. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.096297 · Cited by 269
Soy Consumption, Markers of Inflammation, and Endothelial Function
Azadbakht, L., Kimiagar, M., Mehrabi, Y., Esmaillzadeh, A., Hu, F. B., & Willett, W. C. (2007) · Diabetes Care · doi:10.2337/dc06-2126 · Cited by 178
APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic Syndrome
Miller, M., Rhyne, J., Chen, H., Beach, V., Ericson, R., Luthra, K., Dwivedi, M., & Misra, A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.013 · Cited by 89
Metadata
- Authors
- Hamid, Y. H., Rose, C. S., Urhammer, S. A., Gl�mer, C., Nols�e, R., Kristiansen, O. P., Mandrup-Poulsen, T., Borch-Johnsen, K., Jorgensen, T., Hansen, T., & Pedersen, O.
- Venue
- Diabetologia
- Published
- 2005-01-11
- Volume
- 48
- Issue
- 2
- Pages
- 251-260
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2056228475
- Cited by
- 159
- References
- 8
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.